Scholar Rock Holding SRRK
NASDAQ SRRK
$55.58 -0.36 (-0.64%)
As of: Sep 4, 2026 · 2:23 PM EDT

Scholar Rock Holding (SRRK) Enterprise Value (2018 - 2026)

Scholar Rock Holding (SRRK) posted quarterly Enterprise Value of -$479.9 million for Q1 2026, down 31.72% year-over-year from -$702.9 million in Q1 2025, and down 30.57% quarter-over-quarter from -$367.6 million in Q4 2025.

Analysis

Scholar Rock Holding (SRRK) Enterprise Value (2018 - 2026) Analysis & Trends

Scholar Rock Holding's Enterprise Value history runs 10 years deep, the most recent figure standing at -$479.9 million for Q1 2026.

  • In Q1 2026, Enterprise Value fell 31.72% year-over-year to -$479.9 million; the TTM figure through Mar 2026 stood at -$479.9 million (down 31.72% YoY), while the FY2025 annual figure was -$367.6 million, up 15.94% from the prior year.
  • Enterprise Value for Q1 2026 stood at -$479.9 million, down from -$367.6 million in the prior quarter.
  • The five-year high for Enterprise Value was -$139.1 million in Q3 2024, with the low at -$479.9 million in Q1 2026.
  • The 5-year median for Enterprise Value is -$295.0 million (2025), against an average of -$302.6 million.
  • The sharpest annual moves came in 2024 and 2025: Enterprise Value soared 36.39% in 2024, then tumbled 165.8% in 2025.
  • Scholar Rock Holding's Enterprise Value stood at -$315.4 million in 2022, then advanced by 11.23% to -$279.9 million in 2023, then sank by 56.21% to -$437.3 million in 2024, then grew by 15.94% to -$367.6 million in 2025, then tumbled by 30.57% to -$479.9 million in 2026.
  • Business Quant data shows SRRK's Enterprise Value at -$479.9 million in Q1 2026, -$367.6 million in Q4 2025, and -$369.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn
5 Revolution Medicines 44.07 Bn 44.07 Bn -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn
10 Scholar Rock Holding 7.26 Bn 7.26 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.20 Bn
Mar 31, 2026 5.38 Bn
Dec 31, 2025 4.41 Bn
Sep 30, 2025 3.32 Bn
Jun 30, 2025 3.11 Bn
Mar 31, 2025 2.69 Bn
Dec 31, 2024 3.62 Bn
Sep 30, 2024 502.39 Mn
Jun 30, 2024 475.84 Mn
Mar 31, 2024 1.18 Bn
Dec 31, 2023 1.15 Bn
Sep 30, 2023 353.67 Mn
Jun 30, 2023 355.36 Mn
Mar 31, 2023 361.60 Mn
Dec 31, 2022 152.28 Mn
Sep 30, 2022 206.14 Mn
Jun 30, 2022 -142.18 Mn
Mar 31, 2022 244.82 Mn
Dec 31, 2021 621.60 Mn
Sep 30, 2021 896.04 Mn